Results of Annual General Meeting

RNS Number : 2095B

Advanced Medical Solutions Grp PLC

08 June 2021

 

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Results of Annual General Meeting

Winsford, UK, 8 June 2021 - Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company , announces that at the Company's Annual General Meeting held today at 11 am at Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 30 April 2021.

The poll results were as follows.

Resolution	Title	For (see note 2)		Against (see note 2)
		No. of shares	%	No. of shares	%
1	Receive Annual Report and Accounts	120,604,593	99.99	330,181	0.01
2	Approve the Remuneration Report	120,394,128	99.73	5,741,835	0.27
3	Re-appoint Deloitte LLP as auditors	114,997,737	95.24	12,404,976	4.76
4	Re-elect Peter Allen	108,344,248	89.73	7,340,112	10.27
5	Re-elect Penny Freer	108,168,473	93.65	107,035	6.35
6	Elect Grahame Cook	120,642,189	99.91	596,840	0.09
7	Re-elect Chris Meredith	120,152,803	99.51	335,974	0.49
8	Re-elect Eddie Johnson	120,413,250	99.72	500	0.28
9	Declare final dividend	120,757,509	99.99	411,061	0.01
10	Authorise allotment of shares	115,674,585	99.65	12,886,611	0.35
11	Disapply pre-emption rights*	107,809,178	89.32	897,163	10.68
12	Authorise purchase of own shares*	94,716,196	99.06	330,181	0.94

*  Special Resolution

Notes: 1.  Votes "For" and "Against" are expressed as a percentage of votes received. 2.  A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution. 3.  Total number of shares in issue at close of business on 4 June = 215,650,692 shares. 56% of the voting capital was instructed.

- Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Matthew Cole	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Gary Clarence / Patrick Robb

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and woundcare markets, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand^®, RESORBA^®, LiquiBandFix8^® and Seal-G^®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal^® brand as well as under white label. In 2019, the Group made two acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; and Biomatlante, an established developer and manufacturer of innovative surgical biomaterial technologies based in France. In 2020, the Group acquired Raleigh Adhesive Coatings, a leading coater and converter of materials predominately for woundcare and bio-diagnostics products based in the UK.

AMS's products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has approximately 700 employees. For more information, please see www.admedsol.com .

 

END

 

 

RAGSSFFDAEFSEEM